Lumbar surgery AI planner, tracker gets regulatory green light

A machine learning system for planning spine surgery that also predicts post-op spinal alignment six months out has cleared the FDA’s 510(k) review process.

The OK went to Medtronic for a new degenerative spine algorithm within its UNiD Spine Analyzer v4.0 platform.

The algorithm enables surgeons to pre-plan operations on the lumbar spine and track patients longitudinally, checking results of the surgery as the spine compensates over time, according to a Medtronic announcement sent July 14.

The company says the tracking function combines serial X-ray follow-ups with patient-reported symptoms or symptom relief.

The new update also includes improvements to pediatric and adult spinal-deformity algorithms, Medtronic says, adding that it’s the first and only company to offer FDA-cleared predictive models for spine surgery.

“[W]e have expanded our UNiD Adaptive Spine Intelligence (ASI) technology to include hardware and software solutions dedicated to helping spine surgeons treat degenerative spinal pathologies, where the majority of spine surgery is performed,” comments Dan Wolf, a VP and GM in Medtronic’s neuroscience business.

The company says its UNiD ASI platform uses a database of more than 10,000 surgical cases to train and refine algorithms for visualizing various permutations. Prior to operating, surgeons can use the visualizations to customize technical interventions and personalize care plans.

News release here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.